FDA lets device makers skip paper warnings—if you can find them online
S. 4519 — Medical Device Electronic Labeling Act · Filed by Jim Banks (R-IN) · 1 cosponsor · Introduced May 13, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill allows medical device manufacturers to provide required labeling (instructions, warnings, dosage information) exclusively in electronic form rather than on paper, provided users can easily access it online and request paper copies at no cost. The FDA retains authority to require paper labeling for certain high-risk devices or patient-use products where electronic-only labeling poses safety risks.
Why we flagged it
The bill modernizes FDA labeling rules to permit electronic-only formats, framed as efficiency and accessibility, but shifts compliance burden from manufacturers to users and creates potential safety gaps for populations with limited digital access or literacy.
What the text implies
- Manufacturers may reduce paper labeling costs significantly, but users without internet access, digital literacy, or stable connectivity may not receive critical safety warnings, creating a two-tiered safety system.
- The bill requires manufacturers to provide paper copies 'upon request' and 'without additional cost,' but does not specify enforcement mechanisms, timelines for fulfillment, or penalties for non-compliance, potentially allowing delays in safety-critical information.
The full analysis lists 5 implications of this text.
Who stands to gain
pharmaceutical and medical device manufacturers (reduced printing, packaging, and distribution costs; in vitro diagnostic device manufacturers; healthcare facility operators (reduced physical storage and inventory management)